The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”
https://doi.org/10.15829/1560-4071-2018-11-50-56
Abstract
Aim. Transcatheter aortic valve replacement in patients with high and extremely high risk has become a routine procedure in many cardiac surgery clinics. Until recently, there were no transcatheter prostheses produced within Russia. This article analyzes the results of applying the first domestic transcatheter aortic valve prosthesis MedLabKT.
Material and methods. In the period from June 2018 to October 2018, 7 operations of transcatheter aortic valve replacement were made using the MedLabKT prosthesis. In all cases, implantation was performed by transapical access.
Results. We noted one death. In all cases, paraprosthetic regurgitation was not registrated or was not significant. There are no cases of dislocation of the prosthesis. There were no complications associated with access. In one case, implantation was complicated by myocardial infarction.
Conclusion. The first experience of implantation demonstrated the efficacy and safety of using the MedLabLT prosthesis for transcatheter aortic valve replacement. The analysis of longterm results is required.
About the Authors
A. V. Bogachev-Prokofiev
E. N. Meshalkin National Medical Research Center of the Ministry of Health.
Russian Federation
Russian Federation
R. M. Sharifulin
E. N. Meshalkin National Medical Research Center of the Ministry of Health.
Russian Federation
Russian Federation
D. D. Zubarev
E. N. Meshalkin National Medical Research Center of the Ministry of Health.
Russian Federation
Russian Federation
A. M. Karaskov
E. N. Meshalkin National Medical Research Center of the Ministry of Health.
Russian Federation
Russian Federation
References
1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. doi:10.1093/eurheartj/ehx391.
2. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-8.
3. Kim WK, Hamm CW. Transcatheter aortic valve implantation in Germany. Clin Res Cardiol. 2018;107:81-7. doi:10.1007/s00392-018-1297-0.
4. Perrin N, Frei A, Noble S. Transcatheter aortic valve implantation: Update in 2018. Eur J Intern Med. 2018 Sep;55:12-19. doi:10.1016/j.ejim.2018.07.002.
5. Bockeria LA, Gudkova RG, Milievskaya EB, et al. Cardiovascular surgery – 2015. Diseases and congenital anomalies of the circulatory system. M.: A.N. Bakoulev Scientific Center for Cardiovascular Surgery, 2017. p. 228. Russian
6. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6-23. doi:10.1016/j.jtcvs.2012.09.002.
7. Kretov EI, Kozyr KV, Tarkova AR, et al. Transcatheter implantation of a new prototype of self-expanding aortic valve prosthesis: first experience. Circulation Pathology and Cardiac Surgery 2016; 4:83-7. (In Russ.)
8. Bogachev-Prokophiev AV, Zhuravleva IYu, Sharifulin RM, et al. In vivo implantation of a new transcatheter prosthesis in mitral valve position. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2018;1:22-8. (In Russ.).
9. Sharifulin R, Bogachev-Prokophiev A, Demin I, et al. Right ventricular outflow tract reconstruction using a polytetrafluoroethylene conduit in Ross patients. Eur J Cardiothorac Surg. 2018;54:427-33. doi:10.1093/ejcts/ezy128.
10. Bazylev V.V., Voevodin A.B., Zakharova A.S., et al. Early clinical and hemodynamic results of transcatheter aortic valve implantation using the “MedLab-KT” prosthesis. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2018;3:17-24. (in Russ.)
11. Ando T, Takagi H, Grines CL. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths. Interact Cardiovasc Thorac Surg. 2017;25:484-92. doi:10.1093/icvts/ivx150.
12. Biere L, Pinaud F, Delépine S, et al. CMR assessment after a transapical-transcatheter aortic valve implantation. Eur J Radiol. 2014;83:303-8. doi:10.1016/j.ejrad.2013.11.007.
13. Bleiziffer S, Piazza N, Mazzitelli D, et al. Apical-access-related complications associated with trans-catheter aortic valve implantation. Eur J Cardiothorac Surg. 2011;40:469-74. doi:10.1016/j.ejcts.2010.11.076.
14. Conrotto F, D’Ascenzo F, Francesca G, et al. Impact of access on TAVI procedural and midterm follow-up: a meta-analysis of 13 studies and 10,468 patients. J Interv Cardiol. 2014;27:500–8. doi: 10.1111/joic.12141.
15. Liu Z, He R, Wu C, et al. Transfemoral versus transapical aortic implantation for aortic stenosis based on no significant difference in logistic EuroSCORE: a meta-analysis. Thorac Cardiovasc Surg. 2016;64:374–81. doi:10.1055/s-0035-1555606.
Review
For citations:
Bogachev-Prokofiev A.V., Sharifulin R.M., Zubarev D.D., Karaskov A.M. The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”. Russian Journal of Cardiology. 2018;(11):50-56. (In Russ.) https://doi.org/10.15829/1560-4071-2018-11-50-56
Views:
1080
Email this article 